Pancreas Transplantation: Current Challenges, Considerations, and Controversies

Author:

Fridell Jonathan A1ORCID,Stratta Robert J2ORCID,Gruessner Angelika C3ORCID

Affiliation:

1. Department of Surgery, Indiana University School of Medicine , Indianapolis, IN 46202 , USA

2. Department of Surgery, Atrium Health Wake Forest Baptist Health , Winston-Salem, NC 27157 , USA

3. Department of Medicine/Nephrology, SUNY Downstate Medical Center , Brooklyn, NY 11203 , USA

Abstract

AbstractPancreas transplantation (PTx) reestablishes an autoregulating source of endogenous insulin responsive to normal feedback controls. In addition to achieving complete β-cell replacement that frees the patient with diabetes from the need to monitor serum glucose and administer exogenous insulin, successful PTx provides counterregulatory hormone secretion and exocrine function. A functioning PTx mitigates glycemic variability, eliminates the daily stigma and burden of diabetes, restores normal glucose homeostasis in patients with complicated diabetes, and improves quality of life and life expectancy. The tradeoff is that it entails a major surgical procedure and requisite long-term immunosuppression. Despite the high likelihood of rendering patients euglycemic independent of exogenous insulin, PTx is considered a treatment rather than a cure. In spite of steadily improving outcomes in each successive era coupled with expansion of recipient selection criteria to include patients with a type 2 diabetes phenotype, a decline in PTx activity has occurred in the new millennium related to a number of factors including: (1) lack of a primary referral source and general acceptance by the diabetes care community; (2) absence of consensus criteria; and (3) access, education, and resource issues within the transplant community. In the author's experience, patients who present as potential candidates for PTx have felt as though they needed to circumvent the conventional diabetes care model to gain access to transplant options. PTx should be featured more prominently in the management algorithms for patients with insulin requiring diabetes who are failing exogenous insulin therapy or experiencing progressive diabetic complications regardless of diabetes type. Furthermore, all patients with diabetes and chronic kidney disease should undergo consideration for simultaneous pancreas-kidney transplantation independent of geography or location.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference64 articles.

1. Pancreas transplantation: indications and consequences;Larsen;Endocr Rev,2004

2. Prediction of the long-term metabolic success of the pancreatic graft function;Battezzati;Transplantation,2001

3. Pancreas-after-islet transplantation in nonuremic type 1 diabetes: a strategy for restoring durable insulin independence;Wisel;Am J Transplant,2017

4. Early postoperative continuous glucose monitoring in pancreas transplant recipients;Mittal;Transplant Int,2015

5. Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation;Dadlani;Clin Transplant,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3